GE Healthcare has been in existence for over 100 years and is a leading global medical technology and life sciences company that provides a broad portfolio of products, solutions and services used in the diagnosis, treatment and monitoring of patients.
Our portfolio stretches across a suite of solutions, providing high quality and efficient solutions; it includes diagnostic imaging solutions, clinical care solutions, IT & Digital solutions as well as Life Care Solutions.
We not only offer a full range of healthcare products but also support customers and healthcare professionals through training and education delivered by clinical specialists who offer hands on training as well as various refresher trainings. Our goal is to deliver increased capacity, improved productivity, and better patient outcomes for our customers.
Our Mantra at GE Healthcare is “Intelligently Efficient”
The true potential of nuclear medicine is its ability to enable a true discovery. A true discovery is different, because it provides reproducible evidence that reveals a greater truth about the human body. A truth that has the ability to not only change the life of one patient, but to transcend an individual to benefit all patients.
Everything we do is with the purpose of providing you with the tools you need to go in search of true discovery. In nuclear medicine, this means a commitment to making it more accessible and increasing the value of its results to referring physicians. The result of this commitment is a wide array of technologies designed to help you deliver better patient outcomes.
Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips has been present in Africa for over 125 years and is committed to providing effective solutions to the continent’s diverse markets. Philips has a comprehensive understanding of the complexities of the African market as well as the key challenges facing Africa today and is rapidly increasing presence on the continent by developing local talent and organizations, increasing its commercial footprint and introducing innovative products and solutions which are relevant for the local needs.
With over a century of experience in the region, we have a direct presence in 6 countries – Egypt, Algeria, Morocco, Ghana, Kenya and South Africa (corporate HQ). The rest of Africa is served through 150 channel partners throughout the continent. We operate two business divisions – Health Systems and Personal Health. Philips is leading the drive for the digitalization of healthcare in Africa, and has a long history of supporting various Ministries of Health in Large Scale, countrywide Healthcare Revitalization Projects. The company maintains a holistic, long-term approach of partnering with local stakeholders to improve local healthcare infrastructure and contribute to clinical training and training of local healthcare professionals
News from Philips is located at www.philips.com/newscenter
AXIM Nuclear & Oncology (Pty) LTD is a wholly owned subsidiary of AXIM (Pty) LTD.
In September 2019, AXIM (Pty) Ltd formed a wholly owned subsidiary company: AXIM Nuclear & Oncology (Pty) Ltd to focus on and expand its Nuclear Medicine, Radiation Oncology, Laboratory & Scientific, and Radiopharmaceutical business.
Our product portfolio includes:
Nuclear Medicine equipment & consumables, Radiation Oncology equipment & consumables, Laboratory & Scientific equipment & consumables, as well as Radiopharmaceuticals & Radiopharmaceutical production equipment and consumables.
We deal with all government and private institutions through our branches in Gauteng, Free State, Kwa-Zulu Natal, Eastern Cape, and Western Cape. We have a strong presence in Sub-Sahara Africa directly and through distributors and agents.
Axim Nuclear & Oncology is the exclusive distributor for many renowned manufacturers from America, Europe, and China.
The AXIM Group of Companies presently employ over 270 personnel, and AXIM Nuclear & Oncology presently employ over 60 personnel.
Our specialized team consists of Sales Specialists, Product and Application Specialists, Pharmacists, Technicians, Administration and Commercial staff, Logistics staff, Physicists, Service Manager, Sales Managers and Business Development Managers.
AEC-Amersham | NTP
AEC-Amersham SOC Ltd aims to be the leading supplier to the Southern African market of products and services for the Healthcare, Life Sciences and Quality & Safety Assurance (QSA) market segments. The company is a wholly owned subsidiary of NTP Radioisotopes SOC Ltd. The Group’s annual turnover is in excess of R1 billion and customers are in 60 countries on 5 continents.
Our product portfolio is aimed at the public and private sectors and includes Universities, Academic Hospitals, Pathology Groups, Pharmaceutical Companies, Industrial laboratories, Food and Beverage manufacturers as well as Agriculture and Veterinary Institutes.
Products are supplied and serviced via the head office in Johannesburg and branches in Cape Town, Durban and Bloemfontein and agents in other centres and export territories.
Our core strengths are an extensive range of specialised products and services supported by a dedicated and knowledgeable sales force whose skills are continuously upgraded.
Business portfolios are revised and expanded within our existing areas of competence so as to grow the company in accordance with shareholder requirements whilst at all times maintaining a reputation of service excellence, thereby benefiting customers, suppliers and employees.
CAPE PET-CT CENTRE
DR H.R MORKEL INC
LAKE, SMIT & PARTNERS
NUCLEAR MEDICINE IMAGING AND THERAPY CENTRE
Located near Aix-en-Provence, in France, PMB is a 150-employee SMB. With a strong expertise in brazing, the company designs and manufactures complex mechanical assemblies and components (ceramic-metal, radio-frequency…), linear particle accelerators and cyclotrons. PMB is part of the French group ALCEN.
PMB has developed a cutting-edge, automated radiopharmaceutical production system for PET imaging, combining a cyclotron with a robotized radiochemistry room, as well as a small microfluidic synthesizer for radiotracer development. A 12 MeV superconducting cyclotron produces 18F, 11C and 68Ga radio-isotopes, which are used to label a targeting agent in a robotized radiochemistry room. Quality control is then carried out through an automated process to test the synthesized molecule.
iMiGiNE provides an unprecedented solution to current limitations in the radiopharmaceutical production and distribution process, by relocating the production close to the patient and expanding the spectrum of possibilities in the field of molecular imaging. Furthermore, by allowing same-day diagnosis with multiple more specific radiopharmaceuticals, iMiGiNE improves patient care.